Development of the anti-IL-10 mAb MK-1966 in combination...

Development of the anti-IL-10 mAb MK-1966 in combination with in situ vaccination of a TLR9 agonist SD-101 for cancer immunotherapy

Phan, U., Ueda, R., Mangadu, R., Sathe, M., Rimmer, E., Vives, F., Ayanoglu, G., Yu, Y., Wong, J., Sadekova, S., McClanahan, T., Bhagwat, B., Willingham, A., Raubertas, R., Kastelein, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)32870-2
Date:
December, 2016
File:
PDF, 58 KB
english, 2016
Conversion to is in progress
Conversion to is failed